Joaquín Campos Franco

Joaquín Campos Franco

Auto-generated profile, based on publicly available information

Joaquín Campos Franco

Hospital São Lucas. Ribeirão Preto (SP), Brasil

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2007 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
AGArturo Gonzalez-Quintela
Arturo Gonzalez-Quintela
RAR. Alende
R. Alende
FGF. Gude
F. Gude
JCJ. Campos
J. Campos
JRJ. Rey
J. Rey
CVC. Vidal
C. Vidal
Summary: The present study investigated serum immunoglobulin (Ig) concentrations in relation to demographic factors, common habits (alcohol consumption and smoking) and metabolic abnormalities in an adult population-based survey including 460 individuals. Serum levels of interleukin (IL)-6, a marker of inflammation, were also determined. After adjusting for confounders, male sex was associated positively with IgA levels and negatively with IgM levels. Age was associated positively with IgA and IgG levels. Smoking was associated negatively with IgG levels. Heavy drinking was associated positively with IgA levels. Metabolic abnormalities (obesity and metabolic syndrome) were associated positively with IgA levels. Abdominal obesity and hypertriglyceridaemia were the components of metabolic syndrome associated most strongly with serum IgA. Heavy drinkers with metabolic syndrome showed particularly high serum IgA levels. Serum IL-6 levels were correlated positively with IgA and IgG concentrations. It is concluded that sex, age, alcohol consumption, smoking and common metabolic abnormalities should be taken into account when interpreting serum levels of IgA, IgG and IgM.

22 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AGArturo Gonzalez-Quintela
Arturo Gonzalez-Quintela
MAManuela Alonso
Manuela Alonso
JCJoaquin Campos
Joaquin Campos
LVLuis Vizcaino
Luis Vizcaino
LLLourdes Loidi
Lourdes Loidi
FGFrancisco Gude
Francisco Gude
Assessment of serum concentration of lipopolysaccharide (LPS)-binding protein (LBP) has been suggested as a useful biomarker to indicate activation of innate immune responses to microbial products. We investigated LBP concentrations and associations with demographics, lifestyle factors, and common metabolic abnormalities in adults. We also examined if LBP concentrations were associated with common polymorphisms in genes coding for LBP (rs2232618), CD14 (rs2569190), and TLR4 (rs4986790), the molecules responsible for the innate immune response to LPS, or serum levels of soluble CD14 (sCD14) and proinflammatory cytokines. Serum LBP was measured with a commercial immunoassay in a random sample of the adult population (n = 420, 45% males, age 18–92 years) from a single municipality. Serum LBP concentrations increased with age (P<0.001) and were higher in individuals who were overweight or obese than in normal-weight individuals (P<0.001). Similarly, LBP concentrations were higher in individuals with metabolic syndrome than in individuals without it (P<0.001). Among metabolic syndrome components, LBP concentrations were independently associated with abdominal obesity (P = 0.002) and low concentrations of HDL-cholesterol (P<0.001). Serum LBP concentrations tended to be independently associated with smoking (P = 0.05), but not with alcohol consumption. Likewise, there was not significant association between LBP concentrations and gene polymorphisms. Concentrations of LBP significantly correlated with serum levels of proinflammatory cytokines (IL-6 and IL-8), sCD14, and with liver enzymes. Serum LBP concentrations increased with age. Overweight, obesity, and having metabolic syndrome (particularly, low HDL cholesterol levels) were associated with higher LBP concentrations. These findings are consistent with microbial exposure playing a role in these inflammatory, metabolic abnormalities.

3 December 2008 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
SLSara Landgren
Sara Landgren
EJElisabet Jerlhag
Elisabet Jerlhag
HZHenrik Zetterberg
Henrik Zetterberg
AGArturo Gonzalez-Quintela
Arturo Gonzalez-Quintela
JCJoaquin Campos
Joaquin Campos
JEJörgen A. Engel
Jörgen A. Engel

1 September 2008 in Alcohol
Verified
Journal Article
Closed access
AGArturo Gonzalez-Quintela
Arturo Gonzalez-Quintela
JCJoaquin Campos
Joaquin Campos
LLLourdes Loidi
Lourdes Loidi
CQCelsa Quinteiro
Celsa Quinteiro
LPLuis-Fernando Perez
Luis-Fernando Perez
FGFrancisco Gude
Francisco Gude

1 January 2006 in Alcohol
Verified
Journal Article
Closed access
AGArturo Gonzalez-Quintela
Arturo Gonzalez-Quintela
Jorge Garcia-GonzalezJorge Garcia-Gonzalez
Jorge Garcia-Gonzalez
JCJ. Campos
J. Campos
LPL.F. Perez
L.F. Perez
MAM.R. Alende
M.R. Alende
STS. Tomé
S. Tomé

25 February 2011 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
JCJoaquin Campos
Joaquin Campos
LRLorena Roca
Lorena Roca
FGFrancisco Gude
Francisco Gude
AGArturo Gonzalez-Quintela
Arturo Gonzalez-Quintela